Interleukin-4 promotes human CD8+ T cell expression of CCR7

Immunology

Volumn 120, Issue 1, 2007, Pages 66-72

  Seneviratne, Suranjith L ^a   Black, Antony P ^a   Jones, Louise ^a   Di Gleria, Kati ^a   Bailey, Abigail S ^a   Ogg, Graham S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Cell differentiation; Cutaneous lymphocyte associated antigen; Cytokines; T cells

Indexed keywords

CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYTOKINE; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; ATOPIC DERMATITIS; ATOPY; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE SEVERITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPH NODE; LYMPHOCYTE HOMING; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; TISSUE SPECIFICITY;

EID: 33845647692     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02478.x     Document Type: Article

References (28)

1. Appay V, Rowland-Jones SL. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol 2004; 16:205-12.
2. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
3. + T lymphocytes. Nature 2001; 410:106-11.
4. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programmes of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187:875-83.
5. van Wely CA, Beverley PC, Brett SJ, Britten CJ, Tite JP. Expression of 1-selectin on Th1 cells is regulated by IL-12. J Immunol 1999; 163:1214-21.
6. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
7. Williams HC, Burney PG, Hay RJ et al. The UK Working Party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131:383-96.
8. Williams HC, Burney PG, Pembroke AC, Hay RJ. Validation of the UK diagnostic criteria for atopic dermatitis in a population setting. UK Diagnostic Criteria for Atopic Dermatitis Working Party. Br J Dermatol 1996; 135:12-7.
9. Berth-Jones J. Six-area, six-sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 (Suppl 48):25-30.
10. Altman JD, Moss P, Goulder P, Barouch DH, McHeyzer WM, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274:94-6.
11. Ogg G, Jin X, Bonhoeffer S, Dunbar P et al. Quantitation of HIV-specific CTL and plasma load of viral RNA. Science 1998; 279:2103-6.
12. Seneviratne SL, Jones L, Bailey AS, Samuel RV, Black AP, Ogg GS. Interleukin-4 induced downregulation of skin homing receptor expression by human viral-specific CD8 T cells may contribute to atopic risk of cutaneous infection. Clin Exp Immunol 2005; 141:107-15.
13. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:1288-96.
14. Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158:1958-62.
15. John M, Lim S, Seybold J, Jose P, Robichaud A, O'Connor B, Barnes PJ, Chung KF. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-62.
16. van den Biggelaar AH, van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG, Yazdanbakhsh M. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356:1723-7.
17. Zuany-Amorim C, Haile S, Leduc D, Dumarey C, Huerre M, Vargaftig BB, Pretolani M. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95:2644-51.
18. Arock M, Zuany-Amorim C, Singer M, Benhamou M, Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 1996; 26:166-70.
19. Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997; 185:1089-99.
20. Wang B, Zhuang L, Fujisawa H et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999; 162:277-83.
21. +) T cells and atopic disease. J Clin Invest 2002; 110:1283-91.
22. Reefer AJ, Carneiro RM, Custis NJ, Platts-Mills TA, Sung SS, Hammer J, Woodfolk JA. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004; 172:2763-72.
23. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. Housedust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992; 89:801-10.
24. + T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999; 163:466-75.
25. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997; 389:978-81.
26. Fuhlbrigge RC, King SL, Dimitroff CJ, Kupper TS, Sackstein R. Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots. J Immunol 2002; 168:5645-51.
27. Teraki Y, Miyake A, Takebayashi R, Shiohara T. In vivo evidence for close association of CLA expression and E-selectin binding by T cells in the inflamed skin. J Dermatol Sci 2004; 36:63-5.
28. Teraki Y, Hotta T, Shiohara T. Skin-homing interleukin-4 and -13-producing cells contribute to bullous pemphigoid: remission of disease is associated with increased frequency of interleukin-10-producing cells. J Invest Dermatol 2001; 117:1097-102.